Related Experiment Video
Updated: Jun 6, 2025

Impact Assessment of Repeated Exposure of Organotypic 3D Bronchial and Nasal Tissue Culture Models to Whole Cigarette Smoke
Published on: February 12, 2015
Intenzivní léčba závislosti na tabáku v Česku v letech 2010-2022
Abstract:
In the 10th version of the World Health Organization's International Classification of Diseases, tobacco dependence is a separate diagnostic unit, F17. As with other diseases, there are effective treatments - psychobehavioral interventions and pharmacotherapy to suppress withdrawal symptoms. The aim of this analysis was to evaluate the development of reporting of selected intensive tobacco dependence treatment interventions in the Czech Republic. Data provided by the National Register of Covered Health Services of the Institute of Health Information and Statistics of the Czech Republic for the period 2010-2022, with a distinction per county and anonymized per centers for tobacco dependence and trained physicians. Between 2010 and 2022, an average of 1094 initial intervention procedures were reported annually in the country, indicating the number of smokers treated, and 2584 control visits. The Centre for Tobacco Dependence of the General University Hospital in Prague had the largest share in the total reporting of 25501 procedures (average 35.5 %). Intensive treatment for tobacco dependence should be offered and available as treatment for other diseases. However, of the approximately two million smokers in the Czech Republic, only about 0.5 ‰ undergo it annually.
Related Concept Videos
CNS Depressants: Alcohol and Nicotine
Drug Dependence
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Stimulants
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...

